NCT05593913View on ClinicalTrials.gov

Clinical Evaluation of VeriSee AMD in Screening for Age-Related Macular Degeneration

CompletedOBSERVATIONAL
Enrollment

986

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

March 3, 2022

Study Completion Date

August 10, 2022

Conditions
Macular Degeneration, Age RelatedMaculopathy, Age Related
Trial Locations (1)

100

National Taiwan University Hospital, Taipei

Sponsors

Lead Sponsor

Acer Medical Inc.
All Listed Sponsors
collaborator

National Taiwan University Hospital

OTHER

lead

Acer Medical Inc.

INDUSTRY

NCT05593913 - Clinical Evaluation of VeriSee AMD in Screening for Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter